Page 1 of 45
123Next ›Last »

2020

Christiansen CF, Farkas DK, Fryzek JP, Romagnani P, Nørgaard M, Rothman KJ, Toft Sørensen H. Risk and prognosis of cancer after acute kidney injury. Presentation to the 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Berlin, Germany, August 2020.

View Abstract

Dronin-Fenton D, Dalvi T, Movva N, Pedersen I, Hansen H, Fryzek J, Mellemgaard A, Rasmussen T, Klein A, Hamilton-Dutoit S, Nørgaard M. PD-L1 expression and survival in stage III unresectable non-small cell lung cancer patients in Denmark. Accepted for presentation to a virtual meeting (due to COVID-19) of the European Society for Medical Oncology (ESMO), abstract #2865, August 2020.

View Abstract

Stalbovskaya V, Wasserman E, Fryzek J, Bylsma LC, Sirulnik A. NRG1 fusion-driven cancers: A systematic literature review and meta-analysis. Abstract presented online at American Society of Clinical Oncology, May 2020 [virtual conference due to COVID-19].

Bylsma LC, Dean R, Lowe K, Sangare L, Alexander D, Fryzek J. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics. Poster for Society of Toxicology, virtual annual meeting, 2020.

View Abstract

Stalbovskaya V, Wasserman E, Fryzek J, Bylsma LC, Sirulnik A. NRG1 fusion-driven cancers: A systematic literature review and meta-analysis. Abstract poster presentation at National Organization for Rare Disorders Summit, October 2020 [virtual conference due to COVID-19].

Haws L (session co-chair). Introduction to “Use of New Approach Methods in Risk Characterization of PFAS: Challenges and Opportunities.” 44th Annual Winter Meeting, the Toxicology Forum, Tysons, VA, Jan 2020 (see: https://dialogue.toxforum.org/d/do/894).

Ring C. Application of high-throughput exposure modeling in risk-based prioritization for PFAS. Presentation at 44th Annual Winter Meeting, the Toxicology Forum, Tysons, VA, Jan 2020 (see: https://dialogue.toxforum.org/d/do/900).

Vater S. Update: New data requirements for sunscreen over the counter additives—Challenges and opportunities. Presentation at 44th Annual Winter Meeting, the Toxicology Forum, Tysons, VA, Jan 2020 (see: https://dialogue.toxforum.org/d/do/913).

Antonijevic T, Shah I. Predicting subchronic and chronic animal toxicity from in vitro high content imaging data using PBTK and machine learning. Poster for Society of Toxicology, Virtual Annual Meeting, 2020.

View Abstract

Chesney A, Welsh B, Kimzey A, Lansita J. The process and challenges of deriving exposure-based limits for toxicological risk assessment for components and impurities present in cell therapy products with case studies. Poster for Society of Toxicology, Virtual Annual Meeting, 2020.

View Abstract
Page 1 of 45
123Next ›Last »